Article | November 17, 2021

Mechanistic Modeling For Downstream Processing: Digital Twins Are Here To Stay

Source: Cytiva

By Tobias Hahn, Principal Scientist, Cytiva

iStock-1214111351-computer-lab

Across many industries, computer simulation has become an essential tool. Bioprocess development is only beginning to establish simulation-based workflows, despite the innovative nature of the biopharmaceutical industry.

Experts in the bioprocess industry agree that expensive and time-consuming laboratory experiments, iterative empirical optimization, and statistical methods alone cannot tackle future challenges. Therefore, many global biopharma companies are working on establishing digital twins of their upstream or downstream processes.

This article explores the types of digital twins as well as mechanistic modeling and chromatography models for the prediction and optimization of existing processes. Discover the important role that fully developed digital twins are likely to play.

VIEW THE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.

Subscribe to Biosimilar Development X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Biosimilar Development